- Home
- PRQR vs EDF Comparison
PRQR vs EDF Comparison
Compare PRQR & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRQR | EDF |
|---|---|---|
| Founded | 2012 | N/A |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.5M | 160.5M |
| IPO Year | 2014 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PRQR | EDF |
|---|---|---|
| Price | $1.51 | $5.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.80 | N/A |
| AVG Volume (30 Days) | ★ 774.0K | 188.6K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.92 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $4.72 |
| 52 Week High | $3.10 | $5.34 |
Technical Indicators
Market Signals| Indicator | PRQR | EDF |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 52.09 |
| Support Level | $1.34 | $5.05 |
| Resistance Level | $1.58 | $5.19 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 0.71 | 47.50 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.